Abstract
Matrix metalloproteinases (MMPs), also termed “matrixins”, constitute a family of zinc metalloendopeptidases that participate in breakdown of extracellular matrix macromolecules (Woessner, 1991). These enzymes are considered to play an important role in many biological processes such as in reproduction, embryogenesis, tissue resorption, and in the control of cell behavior. Overproduction of matrixins is associated with various connective tissue diseases such as arthritis, periodontitis, glomerulonephritis, tissue ulceration as well as being connected with tumor cell invasion and metastasis (Woessner, 1991; Birkedal-Hansen et al., 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bányai, M. J., Tordai, H., and Patthy, L., 1994, The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A), Biochem. J. 298:403–407.
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M.D., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A., 1993, Matrix metalloproteinases: a review, Crit. Rev. Oral Biol. Med. 4:197–250.
Brown, P.D., Levy, A.T., Margulies, I. M. K., Liotta, L. A., and Stetler-Stevenson, W. G., 1990, Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines, Cancer Res 50:6184–6191.
Collier, I. E., Krasnov, P. A., Strongin, A. Y., Birkedal-Hansen, H., and Goldberg, G. I., 1992, Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase, J. Biol. Chem. 267:6776–6781.
Crabbe, T., Willenbrock, F., Eaton, D., Hynds, P., Carne, A. F., Murphy, G., and Docherty, A. J. P., 1992, Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms pro¬posed for other matrix metalloproteinases, Biochemistry. 31:8500–8507.
Crabbe, T., O’Connell, J. P., Smith, B. J., and Docherty, A. J. P., 1994, Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A, Biochemistry 33:14419–14425.
Freije, J. M. P., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J., and López-Otin, C, 1994, Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas, J. Biol. Chem. 269:16766–16773.
Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L., and Stetler-Stevenson, W. G., 1992, Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions, J. Biol. Chem. 267:15398–15404.
Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Manner, B. L., 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin, J. Biol. Chem. 267:4583–4591.
Holz, R. C., Salowe, S. P., Smith, C. K., Cuca, G. C., and Que L., Jr., 1992, EXAFS evidence for a “cysteine switch” in the activation of prostromelysin. J. Am. Chem. Soc. 114:9611–9614.
Howard, E. W., and Banda, M. J., 1991, Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase, J. Biol. Chem. 266:17972–17977.
Knäuper, V, Wilhelm, S. M., Seperack, P. K., DeClerck, Y. A., Langley, K. E., Osthues, A., and Tschesche, H., 1993, Direct activation of human neutrophil procollagenase by recombinant stromelysin, Biochem. J. 295:581–586.
Koklitis, P., Murphy, G., Sutton, C, and Angel, S., 1991, Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities, Biochem. J. 276:217–221.
Morodomi, T, Ogata, Y, Sasaguri, Y, Morimatsu, M., and Nagase, H., 1992, Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukemia and HT1080 fibrosarcoma cells, Biochem. J. 285:603–611.
Murphy G., Houbrechts, A., Cockett, M.I., Williamson, R. A., O’Shea, M., and Docherty, A. J. P., 1991, The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity, Biochemistry 30:8097–8102.
Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. E., Eaton, D., and Docherty, A. J. P., 1992, The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases, Biochem. J. 283:637–641.
Murphy, G., Segain, J.-R, O’Shea, M., Cockett, M., Ioannoum C., Lefebvre, O., Chambon, P., and Basset, P., 1993, The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase, J. Biol. Chem. 268:15435–15441.
Murphy, G., Nguyen, Q., Cockett, M. I., Atkinson, S. J., Allen, J. A., Knight, G. C., Willenbrock, F., and Docherty, A. J. P., 1994, Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant, J. Biol. Chem. 269:6632–6636.
Nagase, H., Enghild, J. J., Suzuki, K., and Salvesen G., 1990, Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate, Biochemistry 39:5783–5789.
Ogata, Y, Enghild, J. J., and Nagase, H., 1992, Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9, J. Biol. Chem. 267:3581–3584.
Okada, Y, and Nakanishi, I., 1989, Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (“gelatinase”) by human neutrophil elastase and cathepsin G, FEBS Lett 249:353–356.
Okada, Y, Harris, E. D., Jr., Nagase, H., 1988, The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-amino-phenylmercuric acetate, Biochem. J. 254:731–741.
Okada, Y, Morodomi, T, Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H., 1990, Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties, Eur. J. Biochem. 194:721–730.
Okada, Y, Gonoji, Y, Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T, 1992, Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties, J. Biol. Chem. 267:21712–21719.
Overall, C. M., and Sodek, J., 1990, Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases, J. Biol. Chem. 265:21141–21151.
Pei, D., Majmudar, G., and Weiss, S. J., 1994, Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3, J. Biol. Chem. 269:25849–25855.
Salowe, S. P., Marcy, A. I., Cuca, G. C. Smith, C. K., Kopka, I. E., Hagmann, W. K., and Hermes, J. D., 1992, Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme, Biochemistry 31:4535–4540.
Sato, H., Takino, T, Okada, Y, Cao. J., Shinagawa, A., Yamamoto, E., and Seiki, M., 1994. A matrix metalloproteinase expressed on the surface of invasive tumor cells, Nature 370:61–65.
Shapiro, S. D., Kobayashi, D. K., and Ley, T. J., 1993, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268:23824–23829.
Springman, E. B., Angleton, E. I. Birkedal-Hansen, H., and Van Wart, H. E., 1990, Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a “cysteine switch” mechanism for activation, Proc. Natl. Acad. Sci. USA 87:364–368.
Suzuki, K., Enghild, J. J., Morodomi, T. Salvesen, G., and Nagase, H., 1990, Mechanisms of activation of tissue procollagenase by matrix metalloproteianse 3 (stromelysin), Biochemistry 29:10261–10270.
Suzuki, K., Lees, M., Newlands, G. F. J., Nagase, H., and Woolley, D. E., 1995, Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II, Biochem. J. 305:301–306.
VanWart, H. E., and Birkedal-Hansen. H., 1990, The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. USA 87:5578–5582.
Wilde, Craig G., Hawkins, P. R., Coleman, R. T., Levine, W. B., Delegeane, A. M., Okamoto, P. M., Ito, L. Y., Scott, R. W., and Seilhamer, J. J., 1994, Cloning and characterization of human tissue inhibitor of metalloproteinases-3, DNA Cell Biol 13:711–718.
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I., 1989, SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages, J. Biol. Chem. 264:17213–17221.
Willenbrock, F., Crabbe, T, Slocombe, P. M., Sutton, C. W., Docherty, A. J. P., Cockett, M. I., O’Shea, M., Brocklehurst, K., Philips, I. R., and Murphy, G., 1993, The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase A, Biochemistry 32, 4330–4337.
Woessner, J. F., Jr., 1991, Matrix metalloproteinaes and their inhibitors in connective tissue remodeling, FASEB J 5:2145–2154.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Nagase, H. et al. (1996). Involvement of Tissue Inhibitors of Metalloproteinases (TIMPS) During Matrix Metalloproteinase Activation. In: Suzuki, K., Bond, J.S. (eds) Intracellular Protein Catabolism. Advances in Experimental Medicine and Biology, vol 389. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0335-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0335-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8003-0
Online ISBN: 978-1-4613-0335-0
eBook Packages: Springer Book Archive